Endothelial function in myocardial protection

Current Opinion in Cardiology

Volumn 11, Issue 6, 1996, Pages 559-563

  Amrani, Mohamed ^a   Yacoub, Magdi H ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARDIOPLEGIC AGENT; FREE RADICAL; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN; NITRIC OXIDE;

AGE; CORONARY ARTERY BLOOD FLOW; CRYSTALLOID; ENDOTHELIUM; HEART MUSCLE ISCHEMIA; HEART PROTECTION; PRIORITY JOURNAL; REPERFUSION INJURY; SHORT SURVEY; TEMPERATURE;

EID: 0029842727     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199611000-00001     Document Type: Short Survey

References (39)

1. Quillen JE, Selke FW, Brooks LA, Harrison DG: Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 1990, 82:586-594.
2. Bolli R, Triana JF, Jeroudi MO: Prolonged impairment of coronary vasodilatation after reversible ischemia: evidence for microvascular stunning. Circulation 1990, 67:332-343.
3. Palmer RMJ, Ferrige A G, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
4. Amrani M, O'Shea J, Allen NJ, Harding SE, Jayakumar J, Pepper JR, Moncada S, Yacoub MH: Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol 1992, 456:681-687.
5. Radomski MW, Palmer RMJ, Moncada S: Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987, 92:181-187.
6. Kubes P, Suzuki M, Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991, 88:4651-55.
7. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mltogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989, 83:1774-1777.
8. Seccombe JF, Pearson PJ, Schaff HV: Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. J Thorac Cardiovasc Surg 1994, 107:505-509.
9. Johnson G, Tsao PC, Lefer AM: Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991, 19:244-52.
10. Tsao PS, Lefer AM: Time course and mechanisms of endothelial dysfunction in isolated ischemic and hypoxlc-perfused rat hearts. Am J Physiol 1990, 259:H1660-H1666.
11. Pinsky DJ, OZ MC, Koga S, Taha Z, Broekman MJ, Marcus AJ, Liao H, Naka Y, Brett J, Cannon PJ, Nowygrod R, Malinski T, Stern DM: Cardiac preservation is enhanced in a heterotopic rat heart transplant model by supplementing the nitric oxide pathway. J Clin Invest 1994, 93:2291-2297.
12. Nakanishi K, Zhao Z-Q, Vinthen-Johansen, Hudspeth DA, McGee DS, Hammon JW: Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg 1995, 109:1146-54. This experimental study showed that addition of an NO donor to blood during cardioplegia significantly improved the postischemic recovery of endothelial and mechanical function.
13. Amrani M, Chester A, Jayakumar J, Schyns CJ, Yacoub MH: L-arginine reverses low reflow and enhances post-ischaemic recovery of cardiac mechanical function. Cardiovasc Res 1995, 30:200-204. In isolated working hearts subjected to a prolonged hypothermic cardioplegic arrest, administration of L-arginine during reperfusion reversed endothelial dysfunction, enhanced NO level, and improved cardiac mechanical function.
14. Pernow J, Uriuda Y, Wang Q-D, Li R, Norlander R, Rydeen L: The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. Eur Heart J 1995, 15:1712-1719.
15. Hiramatsu T, Forbess JM, Miura T, Mayer JE: Effect of L-arginine and L-nitro-arginine methyl esther on recovery of neonatal lamb hearts after cold ischaemia. J Thorac Cardiovasc Surg 1995, 109:81-7.
16. Amrani M, Mankad PS, Yacoub MH: Improved preservation of endothelial function at 4°C. Eur J Cardiothorac Surg 1992, 6:72-78.
17. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB: Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 1988, 82:476-485.
18. Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986, 320:454-456.
19. Rubanyi GM, Vanhoutte PM: Superoxide anion and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986, 250:H822-H827.
20. Amrani M, Shirvani R, Allen NJ, Ledingham S, Yacoub MH: Enhancement of low coronary reflow improves postischemic myocardial function. J Thorac Cardiovas Surg 1992, 104:1375-1382.
21. Amrani M, Ledingham S, Jayakumar J, Allen NJ, Rothery S, Severs N, Yacoub MH: Detrimental effects of temperature on the efficacy of the University of Wisconsin solution when used for cardioplegia at moderate hypothermia: comparison with the SL Thomas' Hospital solution at 4°C and 20°C. Circulation 1992, 86(suppl 2):286-288.
22. Amrani M, Corbett J, Goodwin A, Boateng S, Dunn M, Yacoub MH: Kinetics of induction and protective effect of heat shock protein. Ann Thorac Surg 1996, 61:1407-1412. Induction of heat-shock proteins was associated with an improved postischemic recovery of endothelial and mechanical function. There was a correlation between the level of heat-shock protein and the degree of improvement.
23. Amrani M, Corbett J, Allen NJ, O'Shea J, Boateng S, May A, Dunn M, Yacoub MH: Induction of heat-shock proteins enhances myocardial and endothelial functional recovery after prolonged cardioplegic arrest. Ann Thorac Surg 1994, 57:157-160.
24. Amrani M, Corbett J, Allen NJ, O'Shea J, Dunn M, Tadjkarimi S, Theodoropoulos S, Yacoub MH: Role of catalase and heat-shock protein on recovery of cardiac endothelial and mechanical function after ischemia. Cardioscience 1993, 4:193-198.
25. Amrani M, Chester A, Jayakumar J, Yacoub MH: Ageing reduces postls-chaemic recovery of coronary endothelial function. J Thorac Cardiovasc Surg 1996, 111:238-245.
26. Amrani M, Goodwin AT, Chester A, Gray C, Yacoub MH: Ageing is associated with reduced basal and stimulated release of nitric oxide. Acta Physiol Scandinavica 1996, 157:79-84.
27. Lam JYT, Chesebro JH, Fuster V: Platelets, vasoconstriction and nitroglycerin during arterial wall injury: a new anti-thrombotic role for a old drug. Circulation 1988, 78:712-716.
28. Groves PH, Lewis MJ, Cheadle HA, Penny WJ: SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation 1993, 87:590-597.
29. Fitzgerald DJ, Roy L, Robertson RM, Fitzgerald GA: The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. Circulation 1984, 70:297-302.
30. Laster SB, Rutherford BD, Giorgi LV, et al.: Results of direct percutaneous transluminal angioplasty in octogenarians. Am J Cardiol 1996, 77:10-13.
31. Egashira K, Inou T, Hirooka Y, et al.: Effects of age on endothelium dependent vasodilatation of resistance coronary arteries by acetyl-choline in humans. Circulation 1993, 88:77-81.
32. Folkow B, Svanborg A: Physiology of cardiovascular ageing. Physiol Rev 1993, 73:725-764.
33. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ: Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992, 262:H616-H620.
34. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH, Ignarro: Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest 1994, 93:2658-2666.
35. Waldman SA, Murad F: Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 1988, 12(suppl 5):S115-S118.
36. del Nido PJ, Mickle DAG, Wilson GJ: Evidence of myocardial free radicals injury during elective repair of tetralogy of Fallot. Circulation 1987, 76(suppl):V-174-V-179.
37. Theoh KH, Mickle AG, Weisel RD, LI R, Tumiati LC, Coles JG, Williams WG: Effect of oxygen tension and cardiovascular operation on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorto-coronary bypass. J Thorac Cardiovasc Surg 1992, 104:159-164.
38. Li K, Mickle DAG, Weisel RD: Effect of oxygen tension on the antioxidant enzyme activities of tetralogy of Fallot ventricular myocytes. J Mol Cell Cardiol 1989, 21:567-75.
39. Zweier JL, Wang P, Samouilov A, Kuppusamy P: Enzyme-independent formation of nitric oxide In biological tissue. Nature Med 1995, 1:804-9. This excellent study showed that in isolated hearts subjected to nonprotected ischemia (normothermic ischemia without administration of cardioplegia) nitric oxide level was increased. The nonenzymatic pathway plays a major role and is pH-dependent.